Statements (34)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:antibiotic
|
| gptkbp:administeredBy |
oral route
intravenous route |
| gptkbp:affiliatedWith |
gptkb:macrolide_antibiotics
|
| gptkbp:approvalYear |
1991
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
gptkb:J01FA10
|
| gptkbp:brand |
gptkb:azithromycin
|
| gptkbp:CASNumber |
83905-01-5
|
| gptkbp:chemicalFormula |
C38H72N2O12
|
| gptkbp:contraindication |
hypersensitivity to macrolides
hypersensitivity to azithromycin |
| gptkbp:discoveredBy |
gptkb:Pliva
|
| gptkbp:eliminatedIn |
renal excretion
biliary excretion |
| gptkbp:genericName |
gptkb:azithromycin
|
| gptkbp:halfLife |
68 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Zithromax
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
gptkb:Croatia
gptkb:Pfizer |
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:sideEffect |
nausea
vomiting diarrhea abdominal pain |
| gptkbp:usedFor |
skin infections
ear infections sexually transmitted infections bacterial infections respiratory tract infections |
| gptkbp:bfsParent |
gptkb:azithromycin
gptkb:Azithromycin |
| gptkbp:bfsLayer |
6
|